Pasquali R, Vicennati V, Gambineri A
Département de Médecine Interne et Gastro-entérologie, Hôpital S. Orsola-Malpighi, Bologne, Italie.
Contracept Fertil Sex. 1998 May;26(5):372-5.
Approximately half the women with the polycystic ovary syndrome (PCOS) are obese or overweight. Obesity and body fat distribution have independent roles in the development of hyperandrogenism in PCOS. Most obese and normal weight PCOS are insulin resistant and hyperinsulinemic. Moreover, a significant positive correlation exists between the degree of hyperandrogenism and that of hyperinsulinism. The pathogenetic role of obesity may involve different mechanisms, the major one being the hyperinsulemic state, since insulin is capable of stimulating ovarian androgen secretion and controlling androgen metabolism and transport in peripheral tissues. Abdominal body fat distribution in obese women with PCOS amplifies the degree of hyperandrogenism and related clinical symptoms and signs. Both loss of body weight and/or the reduction of the degree of hyperinsuliemia, induced by diet or insulin-sensitizing drugs, have important effects, since they reduce blood androgen levels and can improve ovulation and clinical signs of hyperandrogenism.
大约一半患有多囊卵巢综合征(PCOS)的女性肥胖或超重。肥胖和体脂分布在PCOS高雄激素血症的发生中具有独立作用。大多数肥胖和体重正常的PCOS患者存在胰岛素抵抗和高胰岛素血症。此外,高雄激素血症程度与高胰岛素血症程度之间存在显著正相关。肥胖的致病作用可能涉及不同机制,主要机制是高胰岛素血症状态,因为胰岛素能够刺激卵巢雄激素分泌并控制外周组织中的雄激素代谢和转运。患有PCOS的肥胖女性腹部体脂分布会加重高雄激素血症程度及相关临床症状和体征。通过饮食或胰岛素增敏药物引起的体重减轻和/或高胰岛素血症程度降低均具有重要作用,因为它们可降低血液雄激素水平,并可改善排卵和高雄激素血症的临床体征。